ABCL vs TSHA
Comparison between AbCellera Biologics Inc (ABCL, Company) and Taysha Gene Therapies Inc (TSHA, Company).
Both ABCL and TSHA are from the Healthcare sector.
5-Year PerformanceTSHA has outperformed ABCL, delivering a return of -24.4% compared to -26.4%
ABCL vs TSHA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
ABCL vs TSHA - Historical Returns
Returns include dividend reinvestment.
ABCL vs TSHA - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | ABCL | TSHA |
|---|---|---|
| 2026 | +63.85% | +4.76% |
| 2025 | +12.87% | +197.30% |
| 2024 | -48.87% | +1.17% |
| 2023 | -39.83% | -19.55% |
| 2022 | -28.36% | -80.94% |
| 2021 | -63.43% | -55.48% |
| 2020 | -31.68% | +10.31% |
ABCL vs TSHA Drawdown Comparison
The maximum drawdown for ABCL was -96.72%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The maximum drawdown for TSHA was -98.14%, occurring on Jun 28, 2023. This drawdown has not yet recovered.
The current ABCL drawdown is -90.46%. The current TSHA drawdown is -82.68%.
| Rank | ABCL | TSHA |
|---|---|---|
| #1 | -96.72% Dec 11, 2020 - Apr 8, 2025 | -98.14% Jan 20, 2021 - Jun 28, 2023 |
| #2 | N/A | -21.78% Sep 25, 2020 - Dec 23, 2020 |
| #3 | N/A | -10.74% Dec 23, 2020 - Jan 14, 2021 |
Correlation
Correlation between ABCL and TSHA is 0.89 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks